142 related articles for article (PubMed ID: 36074242)
1. Incomplete response to therapy in intermediate- and high-risk thyroid cancer.
Alzahrani AS; Mukhtar N
Endocrine; 2022 Dec; 78(3):531-542. PubMed ID: 36074242
[TBL] [Abstract][Full Text] [Related]
2. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
[TBL] [Abstract][Full Text] [Related]
3. The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting.
Wu J; Hu XY; Ghaznavi S; Kinnear S; Symonds CJ; Grundy P; Parkins VM; Sharma P; Lamb D; Khalil M; Hyrcza M; Chandarana SP; Pasieka JL; Harvey A; Warshawski J; Hart R; Deutschman M; Randall DR; Paschke R
Thyroid; 2022 Dec; 32(12):1509-1518. PubMed ID: 36226405
[No Abstract] [Full Text] [Related]
4. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
[TBL] [Abstract][Full Text] [Related]
6. Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer.
Mukhtar N; Aljamei H; Aljomaiah A; Moria Y; Alzahrani AS
Eur Thyroid J; 2021 Jun; 10(3):198-207. PubMed ID: 34178705
[TBL] [Abstract][Full Text] [Related]
7. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
8. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
9. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
10. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
[No Abstract] [Full Text] [Related]
11. Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up.
Samargandy SA; Qorban GN; Aljadani AK; Almufarji SS; Azab AM; Merdad MA; Al-Hajeili MR; Samargandy SJ
Saudi Med J; 2024 Feb; 45(2):139-146. PubMed ID: 38309729
[TBL] [Abstract][Full Text] [Related]
12. Distant Metastasis in Pediatric and Adolescent Differentiated Thyroid Cancer: Clinical Outcomes and Risk Factor Analyses.
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32813019
[TBL] [Abstract][Full Text] [Related]
13. Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer.
Alzahrani AS; Moria Y; Mukhtar N; Aljamei H; Mazi S; Albalawi L; Aljomaiah A
J Endocr Soc; 2021 Jan; 5(1):bvaa178. PubMed ID: 33367194
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
Maino F; Botte M; Dalmiglio C; Valerio L; Brilli L; Trimarchi A; Mattii E; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2024 Feb; 109(3):722-729. PubMed ID: 37804529
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer.
Riguetto CM; Barreto IS; Maia FFR; Assumpção LVMD; Zantut-Wittmann DE
Clinics (Sao Paulo); 2021; 76():e3022. PubMed ID: 34406270
[TBL] [Abstract][Full Text] [Related]
16. Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort Study.
Liu JB; Baugh KA; Ramonell KM; McCoy KL; Karslioglu-French E; Morariu EM; Ohori NP; Nikiforova MN; Nikiforov YE; Carty SE; Yip L
Thyroid; 2023 Jun; 33(6):705-714. PubMed ID: 36974361
[No Abstract] [Full Text] [Related]
17. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
Jeon MJ; Kim WG; Park WR; Han JM; Kim TY; Song DE; Chung KW; Ryu JS; Hong SJ; Shong YK; Kim WB
Eur J Endocrinol; 2014 Jan; 170(1):23-30. PubMed ID: 24088549
[TBL] [Abstract][Full Text] [Related]
18. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
[TBL] [Abstract][Full Text] [Related]
20. Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer.
Campennì A; Ruggeri RM; Siracusa M; Giacoppo G; La Torre F; Saccomanno A; Alibrandi A; Dionigi G; Tuccari G; Baldari S; Giovanella L
Eur J Endocrinol; 2021 Aug; 185(3):397-404. PubMed ID: 34232125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
